This site is intended for healthcare professionals only
LoginRegister
Cohance Lifesciences appoints Rahul Pradhan as VP - Operations to head API Unit III, AnkleshwarCohance Lifesciences appoints Rahul Pradhan as VP - Operations to head API Unit III, Ankleshwar
Cough Syrup Row: Rajasthan Practitioners Shift to Levocloperastine, Ambroxol Amid Dextromethorphan ConcernsDEG impurity above limit found in another cough syrup, Haryana issues alert
Dr Sujiv Nair takes over as Chief People Officer of MSN GroupDr Sujiv Nair takes over as Chief People Officer of MSN Group
Intas Pharma ropes in Sujit Mandal as Associate Vice President - Manufacturing FinanceIntas Pharma ropes in Sujit Mandal as Associate Vice President - Manufacturing Finance
USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three ObservationsUSFDA concludes inspection at Marksans Pharma Goa facility with zero Form 483 observation
Merck Nears USD 6 Billion Terns Pharma Deal Amid Keytruda Patent Expiry PushMerck inks pact with Dr Falk Pharma for certain development, commercialization rights to MK 8690
Biocon Secures USFDA Nod for Generic Liraglutide Prefilled Pens for DiabetesBiocon gets 2 USFDA observations for Visakhapatnam facility
Mankind Pharma Gets Relief as CGST Appellate Authority Drops Rs 1.02 Cr PenaltyMankind Pharma net profit declines 21 percent to Rs 520 crore in Q2
No Promotional Campaigns for GLP-1 Obesity Drugs: CDSCO Cautions Pharma FirmsHealth Ministry Revises BA/BE Study Rules: Minimum Sample Size Set at 18
JnJ wins USFDA approval for subcutaneous Rybrevant Faspro for EGFR-Mutated NSCLCJnJ bags USFDA approval for Caplyta for major depressive disorder
Merck enters into RnD funding agreement with Blackstone Life Sciences for Sacituzumab TirumotecanMerck enters into RnD funding agreement with Blackstone Life Sciences for Sacituzumab Tirumotecan
CDSCO, DoP Told to Find Workable Solution on Revised Schedule M GMP ConcernsZenvision Pharma Gets CDSCO Panel Nod to Conduct BE Study on Rifaximin Sachets
X